Open Access Research article

PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours

Mark J McKeage*, Michael B Jameson, Ramesh K Ramanathan, Joseph Rajendran, Yongchuan Gu, William R Wilson, Teresa J Melink and N Simon Tchekmedyian

BMC Cancer 2012, 12:496  doi:10.1186/1471-2407-12-496

Article Metrics

Total accesses

Article metric FAQ


  • Last 30 days: 51 accesses
  • Last 365 days: 559 accesses
  • All time: 2777 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information